Breaking News

BioScreen Completes FDA Inspection

July 8, 2014

Inspection covered quality system and lab facilities in Torrance, CA

BioScreen Testing Services, Inc. has successfully completed an FDA audit of their lab facility in Torrance, CA, with no 483 citations issued. The inspection covered BioScreen’s quality system as well as all lab facilities, and expanded chemistry and microbiology labs. 
 
"The results from the FDA audit are extremely positive and serve as a testament to the high Quality Standards that BioScreen sets for itself," said Ranil M. Fernando, executive vice president of BioScreen.
 
BioScreen's President, Bradford Rope added, "We are extremely pleased to share this news

Related Compliance:

blog comments powered by Disqus
  • Flexible Manufacturing Strategies

    Kristin Brooks, Contract Pharma||April 4, 2016
    Michael Lehmann of Patheon discusses solutions for pharmaceutical forecasting errors

  • Platinum Press Facility Tour

    Platinum Press Facility Tour

    Kristin Brooks, Contract Pharma||March 23, 2016
    Opens doors to new, 47,000-sq.-ft. packaging facility in Oakland, NJ

  • Biopharma Packaging Equipment Close-up

    Biopharma Packaging Equipment Close-up

    Kristin Brooks, Contract Pharma||March 7, 2016
    Sieghard Schuchmann of OPTIMA discusses biopharma trends impacting packaging equipment, and the latest capabilities

  • Newsmakers: Ian Muir

    Tim Wright, Editor||April 5, 2016
    End-to-End Service

  • Continuous Pharmaceutical Processes and Their Demands

    Continuous Pharmaceutical Processes and Their Demands

    Girish Malhotra, EPCOT International||April 5, 2016
    A look at the unique characteristics of continuous processes in pharmaceutical manufacturing.

  • CMO Systems

    CMO Systems

    Philip K. Burns, CRO Consulting||April 5, 2016
    A CMO system includes four aspects of the product lifecycle: regulatory, technical, compliance, and operations.